Home > Research > Publications & Outputs > Chronic Antipsychotic Treatment Modulates Aroma...


Text available via DOI:

View graph of relations

Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>15/06/2019
<mark>Journal</mark>Journal of Molecular Neuroscience
Issue number2
Number of pages7
Pages (from-to)311-317
Publication StatusPublished
Early online date9/04/19
<mark>Original language</mark>English


Antipsychotic drugs, known as the antagonists of dopaminergic receptors, may also affect a large spectrum of other molecular signaling pathways in the brain. Despite the numerous ongoing studies on neurosteroid action and regulation, there are no reports regarding the influence of extended treatment with typical and atypical neuroleptics on brain aromatase (CYP19A1) expression.
In the present study, we assessed for the first time aromatase mRNA and protein levels in the brain of rats chronically (28 days) treated with olanzapine, clozapine, and haloperidol using quantitative real-time PCR, end-point RT-PCR, and Western blotting.
Both clozapine and haloperidol, but not olanzapine treatment, led to an increase of aromatase mRNA expression in the rat brain.
On the other hand, aromatase protein level remained unchanged after drug administration. These results cast a new light on the pharmacology of examined antipsychotics and contribute to a better understanding of the mechanisms responsible for their action. The present report also underlines the complex nature of potential interactions between neuroleptic pharmacological effects and physiology of brain neurosteroid pathways.